首页> 外国专利> Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill patients and people with malnutrition

Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill patients and people with malnutrition

机译:肠胃营养补充品,用于危重病,慢性病患者和营养不良者的肠胃外营养或部分肠内/口腔营养

摘要

The present invention relates to a supplement to be enterally administered for maintaining or restoring the intestinal barrier of the critically or chronically ill patients or people with malnutrition. Said supplement contains, in the form of a solution (the amounts indicated respectively referring to one daily dose), a) between 15 and 70 g of glutamine and/or a glutamine precursor, b) at least two representatives from the group of substances acting as antioxidants, and c) between 0.5 and 10 g of short-chained fatty acids and/or short-chained fatty acid precursors.
机译:本发明涉及一种肠内补充剂,用于维持或恢复危重或慢性病患者或营养不良者的肠屏障。所述补充剂以溶液的形式(分别指示的量指一日剂量)包含:a)15-70 g的谷氨酰胺和/或谷氨酰胺前体,b)至少两种代表作用的物质c)0.5至10 g的短链脂肪酸和/或短链脂肪酸前体。

著录项

  • 公开/公告号CZ300129B6

    专利类型

  • 公开/公告日2009-02-18

    原文格式PDF

  • 申请/专利权人 FRESENIUS KABI DEUTSCHLAND GMBH;

    申请/专利号CZ20030001337

  • 申请日2001-11-14

  • 分类号A61K9;A61K38;A23L1/30;A23L1/305;A23L33/15;A61K31/05;A61K31/195;A61K31/198;A61K31/20;A61K31/22;A61K31/23;A61K31/24;A61K31/255;A61K31/355;A61K31/375;A61K31/519;A61K31/52;A61K31/525;A61K31/7004;A61K31/7052;A61K31/721;A61K33/04;A61K33/24;A61K33/30;A61K45/06;A61P1/04;A61P1/14;A61P3/02;

  • 国家 CZ

  • 入库时间 2022-08-21 19:28:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号